Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio (2016 - 2021)

Sonoma Pharmaceuticals has reported Interest Coverage Ratio over the past 12 years, most recently at 904.0 for Q2 2021.

  • For Q2 2021, Interest Coverage Ratio changed N/A year-over-year to 904.0; the TTM value through Mar 2022 reached 5886.0, down 1436.37%, while the annual FY2021 figure was 287.42, 37.77% up from the prior year.
  • Interest Coverage Ratio for Q2 2021 was 904.0 at Sonoma Pharmaceuticals, down from 27.6 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 42.25 in Q3 2020 and troughed at 2912.0 in Q1 2017.
  • A 5-year average of 602.75 and a median of 358.58 in 2017 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 230.04% in 2019 and later skyrocketed 106.57% in 2020.
  • Year by year, Interest Coverage Ratio stood at 290.91 in 2017, then fell by 15.4% to 335.71 in 2018, then tumbled by 230.04% to 1108.0 in 2019, then surged by 97.51% to 27.6 in 2020, then crashed by 3175.36% to 904.0 in 2021.
  • Business Quant data shows Interest Coverage Ratio for SNOA at 904.0 in Q2 2021, 27.6 in Q4 2020, and 42.25 in Q3 2020.